QuantumDx
QuantuMDx Gets £15M Investment From Vita Spring IVD Fund for Portable PCR Platform Development
QuantuMDx said it has also entered discussions to accelerate the commercial development of its MDx platform in China and other territories in Southeast Asia.
The firm expects that next year it will launch the final version of a battery-powered instrument that can perform high-level multiplexing and provide test results in 30 minutes.
QuantumDx Gets CE Mark for Rapid Point-of-Care PCR System
The system will launch this week with a SARS-CoV-2 test, but the firm expects to expand its menu to include multiplex syndromic assays.
CARB-X Awards SpeeDx up to $3.7 Million for CT/NG Test on QuantumDx Q-POC
SpeeDx will develop a rapid, portable test for chlamydia and gonorrhea that can determine the latter's antimicrobial susceptibility, as well.
QuantuMDx Raises $15.1M to Support Scale Up of Point-of-Care Molecular Diagnostic System
The firm's CEO said that its MDx system is available for research use and going through CE-IVD marking ahead of its full commercial launch.
Feb 12, 2020
Dec 10, 2019
Ontera, QuantuMDx Partner on Sepsis Test Development
Jan 24, 2018
QuantuMDx Raises $12M
Nov 28, 2016
Oct 28, 2014
Jan 8, 2014